Exclusive direct supply danger warning

Exclusive direct supply leaves patients exposed to single-point failure in PBS supply, says NPSA If monopoly supply arrangements between manufacturers and pharmacies continue, there will be no back-ups to protect patients from such a point of failure in the PBS supply chain, NPSA Chairman Mark Hooper says. Speaking at the Eye for Pharma conference in